Rhinomed Limited is an Australia-based wearable nasal and respiratory technology company. The Company is engaged in the research, development and commercialization of consumer and medical devices. It has developed a nasal technology platform that can improve air flow and provide both drug delivery and diagnostic capabilities. The Company’s products include Mute, Turbine, Pronto Sleep, Pronto Clear and Rhinoswab. The Mute is a nasal technology that is designed to allow the user to manage sleep by breathing more and snoring less. The Turbine is designed to fit comfortably inside the nose and gently open each individual nostril to allow more airflow during sport, physical exertion or focused breathing, such as yoga and meditation. Rhinoswab is a patented comfortable, self-administered nasal swab that provides high-yield sampling and fits existing pathology workflows. Pronto Sleep is a vapor inhaler that gently opens the nose and delivers a soothing blend of four pure essential oils.